Enliven Therapeutics has decided against taking its phase 1-stage solid tumor drug into further development next year in ...

The Mumbai-based firm expects a quick recovery in FY27, and is on track to achieve its target of becoming a $2-billion ...

An official update from Ministry of Science & Technology stated that India's bioeconomy has seen an exponential rise - from ...